Join the club for FREE to access the whole archive and other member benefits.

Ben Adams

Senior editor of FierceBiotech

Business, science and healthcare journalist who has worked as an editor for Pharmafocus (UK), as a group editor for Pharmaceutical Marketing Europe, as well as a features and news writer for the BMJ and the Pharmaceutical Journal.

He has an especial interest in market access, drug pricing and the ethics of the life sciences industry and has been heavily involved in ensuring that the need for greater clinical study transparency remains on the agenda for the industry.

Visit website: https://www.fiercebiotech.com/author/ben-adams

 ben-adams-60979219

 PharmaceuticBen

See also

FierceBiotech

Web resource providing the latest biotech news, articles, and resources related to biotech company news

Details last updated 17-Jul-2020

Articles written by Ben Adams

Centenara Labs, formerly Rejuveron, rebrands to focus on anti-ageing research

Centenara Labs, formerly Rejuveron, rebrands to focus on anti-ageing research

FiercePharma - 23-Sep-2024

Their lead treatment, EA-2353, shows promising safety results for retinitis pigmentosa

AbbVie and Calico extends their collab up to 2025 with a $1 billion deal

AbbVie and Calico extends their collab up to 2025 with a $1 billion deal

FierceBiotech - 27-Jul-2021

Supports ageing research and advancing early-stage projects to phase 2 trials over the next decade

Elevian raises $15M in preclinical work towards clinical antiaging

Elevian raises $15M in preclinical work towards clinical antiaging

FierceBiotech - 24-Nov-2020

rGDF11 in clinic targets multiple age related disease therapies

Casma Therapeutics raises $50m to boost cellular waste management therapies

Casma Therapeutics raises $50m to boost cellular waste management therapies

FierceBiotech - 10-Sep-2020

Novel autophagy-based approaches target muscular dystrophy and other challenging diseases

Deep Longevity investors bet on growing need for aging and longevity biomarkers

Deep Longevity investors bet on growing need for aging and longevity biomarkers

FierceBiotech - 15-Jul-2020

Biological clocks are a moving target so they'll need other researchers to corroborate their analysis